Unit-dose kits containing pertuzumab modified with 2- 4-isothiocyanatobenzyl -diethylenetriaminepentaacetic acid (BzDTPA) were prepared that labeled to high efficiency (>90%) with 111In and met specifications for pharmaceutical quality.
We prepared a unit-dose kit that could be labeled at a cyclotron site or at a radiopharmacy some distance from a cyclotron, examining the amount of peptide, pH, radioprotectant, peptide-to-Al3+ ratio, bulking agent, and buffer needed to achieve a high-yielding product [27].
Patient baseline characteristics were well balanced between treatment arms, including duration of prior imatinib exposure, maximal imatinib dose received, KIT mutational status, and QoL (Table 1).
Consider desert dome kits.
Any activin A secreted by LE6 cell cultures was below the minimum detectable dose of the ELISA kit (data not shown).
The significant PFS advantage observed with the 800 mg day−1 dose in patients with KIT exon 9 mutations in the EORTC-Australian study was not confirmed in the North American S0033 study.
Additionally while sunitinib is a multi-targeting RTKIs, our data indicate that, at clinical dose, targeting PDGFR-β, KIT and CSF1-R does not provide additional efficacy compared to PF-210 and axitinib which are selective inhibitors of VEGF.
Minimum detectable dose with the TPO ELISA kit is 2.78 18.5 pg/ml according to the manufacturer.
De Savigny and Mshinda left Arusha to continue promoting the home kits for re-dosing ITNs elsewhere.
Patients were dispensed study medication kits containing unit-dose containers (each for single use) that were identical for both formulations.
Patients were dispensed study medication kits containing unit-dose (single-use) containers that were identical for both formulations, thereby ensuring masking of patients, investigators and evaluators.
